PT-141

PT-141 (bremelanotide) is an FDA-approved treatment of low sexual desire in women, and is also known to treat sexual arousal disorder in male researchers.

SAVE 15%

more 2 products

SAVE 50%

6 for the price of 3

* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.

Compound Overview

Class of Compound:

Peptide

Mechanism of Action:

PT-141 is an agonist of the melanocortin receptors, with high affinity for MC4R, the stimulation of which increases sexual desire and causes sexual arousal in both men and women

Notable Studies:

Also Known As:

Bremelanotide, bremelanotide acetate, Rekynda, Vyleesi, CID9941379

Research Applications:

Sexual funtion
Male sexual arousal
Anti-inflammatory action

Risks:

Injection-related side effects
Temporarily increases blood pressure
Not FDA approved to treat men.

Chemical Structure

Customer Reviews

Rated 0 out of 5

0 reviews

Rated 5 out of 5

0

Rated 4 out of 5

0

Rated 3 out of 5

0

Rated 2 out of 5

0

Rated 1 out of 5

0

Reviews

Clear filters

There are no reviews yet.

Be the first to review “PT-141”